Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Revolution Medicines Inc shares valued at $105,528 were purchased by JEFFREY TODD CISLINI on Jan 21 ’26. At $116.22 per share, JEFFREY TODD CISLINI acquired 908 shares.
Also, Horn Margaret A sold 75,000 shares, netting a total of over 7,542,023 in proceeds. Following the sale of shares at $100.56 each, the insider now holds 141,053 shares.
Before that, Anders Jack had sold 10,000 shares from its account. In a trade valued at $980,000, the Chief Financial Officer traded Revolution Medicines Inc shares for $98.00 each. Upon closing the transaction, the insider’s holdings decreased to 10,000 shares, worth approximately $12.84 million.
As published in their initiating research note from Wolfe Research on November 18, 2025, Revolution Medicines Inc [RVMD] has been an Outperform and the price target has been revised to $75. Analysts at RBC Capital Mkts started covering the stock with ‘”an Outperform”‘ outlook in a report released in early November. As of October 21, 2025, Mizuho has initiated its “an Outperform” rating for RVMD.
Analyzing RVMD Stock Performance
On last trading session, Revolution Medicines Inc [NASDAQ: RVMD] rose 1.09% to $118.81. The stock’s lowest price that day was $116.55, but it reached a high of $120.53 in the same session. During the last five days, there has been a drop of approximately -1.99%. Over the course of the year, Revolution Medicines Inc shares have jumped approximately 195.84%.
Is Revolution Medicines Inc subject to short interest?
Stocks of Revolution Medicines Inc saw a sharp steep in short interest on 2025-12-31 dropping by -1.48 million shares to 15.31 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 16.79 million shares. A decline of -9.65% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 6.62 of the overall float, the days-to-cover ratio (short ratio) decline to 6.62.
Which companies own the most shares of Revolution Medicines Inc (RVMD)?
In terms of Revolution Medicines Inc share price expectations, FactSet research, analysts set an average price target of 99 in the next 12 months, down nearly -15.77% from the previous closing price of $117.53. Analysts anticipate Revolution Medicines Inc stock to reach 170 by 2026, with the lowest price target being 73. In spite of this, 13 analysts ranked Revolution Medicines Inc stock as Buy at the end of 2026. On September 12, 2025, Raymond James assigned a price target of “a Strong buy” to the stock and resumed coverage with a $72.
